281 related articles for article (PubMed ID: 28691930)
1. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.
Jung K; Heishi T; Khan OF; Kowalski PS; Incio J; Rahbari NN; Chung E; Clark JW; Willett CG; Luster AD; Yun SH; Langer R; Anderson DG; Padera TP; Jain RK; Fukumura D
J Clin Invest; 2017 Aug; 127(8):3039-3051. PubMed ID: 28691930
[TBL] [Abstract][Full Text] [Related]
2. Targeting CXCR4-dependent immunosuppressive Ly6C
Jung K; Heishi T; Incio J; Huang Y; Beech EY; Pinter M; Ho WW; Kawaguchi K; Rahbari NN; Chung E; Kim JK; Clark JW; Willett CG; Yun SH; Luster AD; Padera TP; Jain RK; Fukumura D
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10455-10460. PubMed ID: 28900008
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine promotes human monocyte survival via a reduction in oxidative stress.
White GE; McNeill E; Channon KM; Greaves DR
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2554-62. PubMed ID: 25359863
[TBL] [Abstract][Full Text] [Related]
4. CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice.
Jacquelin S; Licata F; Dorgham K; Hermand P; Poupel L; Guyon E; Deterre P; Hume DA; Combadière C; Boissonnas A
Blood; 2013 Aug; 122(5):674-83. PubMed ID: 23775714
[TBL] [Abstract][Full Text] [Related]
5. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
[TBL] [Abstract][Full Text] [Related]
6. Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade.
Rigamonti N; Kadioglu E; Keklikoglou I; Wyser Rmili C; Leow CC; De Palma M
Cell Rep; 2014 Aug; 8(3):696-706. PubMed ID: 25088418
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
Kuboi Y; Nishimura M; Ikeda W; Nakatani T; Seki Y; Yamaura Y; Ogawa K; Hamaguchi A; Muramoto K; Mizuno K; Ogasawara H; Yamauchi T; Yasuda N; Onodera H; Imai T
Int Immunol; 2019 Apr; 31(5):287-302. PubMed ID: 30668715
[TBL] [Abstract][Full Text] [Related]
8. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages.
Donnelly DJ; Longbrake EE; Shawler TM; Kigerl KA; Lai W; Tovar CA; Ransohoff RM; Popovich PG
J Neurosci; 2011 Jul; 31(27):9910-22. PubMed ID: 21734283
[TBL] [Abstract][Full Text] [Related]
9. CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes.
Liu C; Luo D; Streit WJ; Harrison JK
J Neuroimmunol; 2008 Jul; 198(1-2):98-105. PubMed ID: 18508133
[TBL] [Abstract][Full Text] [Related]
10. Ly6Chigh Monocytes Protect against Kidney Damage during Sepsis via a CX3CR1-Dependent Adhesion Mechanism.
Chousterman BG; Boissonnas A; Poupel L; Baudesson de Chanville C; Adam J; Tabibzadeh N; Licata F; Lukaszewicz AC; Lombès A; Deterre P; Payen D; Combadière C
J Am Soc Nephrol; 2016 Mar; 27(3):792-803. PubMed ID: 26160897
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
[TBL] [Abstract][Full Text] [Related]
12. Vascular expression of the chemokine CX3CL1 promotes osteoclast recruitment and exacerbates bone resorption in an irradiated murine model.
Han KH; Ryu JW; Lim KE; Lee SH; Kim Y; Hwang CS; Choi JY; Han KO
Bone; 2014 Apr; 61():91-101. PubMed ID: 24401612
[TBL] [Abstract][Full Text] [Related]
13. Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition.
Morimura S; Sugaya M; Sato S
Am J Pathol; 2013 May; 182(5):1640-7. PubMed ID: 23470165
[TBL] [Abstract][Full Text] [Related]
14. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
Stolla M; Pelisek J; von Brühl ML; Schäfer A; Barocke V; Heider P; Lorenz M; Tirniceriu A; Steinhart A; Bauersachs J; Bray PF; Massberg S; Schulz C
PLoS One; 2012; 7(8):e43572. PubMed ID: 22916279
[TBL] [Abstract][Full Text] [Related]
15. CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.
Peng X; Zhang J; Xiao Z; Dong Y; Du J
J Immunol; 2015 Sep; 195(6):2797-805. PubMed ID: 26254342
[TBL] [Abstract][Full Text] [Related]
16. Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles.
Yamamoto S; Kato A; Sakurai Y; Hada T; Harashima H
J Control Release; 2017 Apr; 251():1-10. PubMed ID: 28192155
[TBL] [Abstract][Full Text] [Related]
17. "γδT Cell-IL17A-Neutrophil" Axis Drives Immunosuppression and Confers Breast Cancer Resistance to High-Dose Anti-VEGFR2 Therapy.
Zhang Z; Yang C; Li L; Zhu Y; Su K; Zhai L; Wang Z; Huang J
Front Immunol; 2021; 12():699478. PubMed ID: 34721375
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CX
Becker F; Holthoff C; Anthoni C; Rijcken E; Alexander JS; Gavins FN; Spiegel HU; Senninger N; Vowinkel T
Int J Colorectal Dis; 2017 Mar; 32(3):315-324. PubMed ID: 27942903
[TBL] [Abstract][Full Text] [Related]
20. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization.
Cochain C; Rodero MP; Vilar J; Récalde A; Richart AL; Loinard C; Zouggari Y; Guérin C; Duriez M; Combadière B; Poupel L; Lévy BI; Mallat Z; Combadière C; Silvestre JS
Cardiovasc Res; 2010 Oct; 88(1):186-95. PubMed ID: 20501509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
